USANA Q2 adjusted profit beats estimate

USANA Health Sciences

22/07/2025 21:25

Overview

USANA fiscal Q2 net sales grow 11% yr/yr, beating analyst expectations, per LSEG data

Adjusted EPS for fiscal Q2 rises to $0.74, exceeding estimates, per LSEG data

Company reiterates fiscal year 2025 outlook, despite decline in active customers

Outlook

USANA reiterates fiscal 2025 net sales outlook of $920 mln to $1 bln

Company expects fiscal 2025 adjusted EPS of $2.35 to $3.00

USANA anticipates 8% to 17% sales growth in fiscal 2025

Hiya sales expected to grow 29% to 42% in fiscal 2025

Result Drivers

COMMERCIAL STRATEGY - USANA attributes 11% net sales growth to its comprehensive commercial strategy, including enhanced incentives and brand messaging

HIYA PARTNERSHIP - Hiya's strong quarter driven by new partnership with Disney, boosting sales and subscriber growth

CUSTOMER DECLINE - Active customer numbers fell across regions, impacting overall performance

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Beat
$235.85 mln
$225.20 mln (1 Analyst)
Q2 Adjusted EPS
Beat
$0.74
$0.54 (1 Analyst)

Analyst Coverage

Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00, about 50.3% above its July 21 closing price of $30.29

The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nBw7pmJNga

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)